Thank you for the question. Our partners are Trek Therapeutics.
Our goal is to develop a system that is robust enough that Trek can submit data to support our manufacturing application for regulatory approval of our drugs from the FDA and EMA authorities, said Dr. Ann Kwong, co-founder and CEO of Trek Therapeutics. Additionally, patients currently have no way to ascertain the quality of the medicines they ingest.
https://coinjournal.net/ambrosus-aims-greater-transparency-food-retail-new-blockchain-p2p-marketplace/Thank you for answering this. Do you expect any big players to step in also?